Compare Agilent Technologies Inc (A) vs Manchester United PLC (MANU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Manchester United PLC — how do they compare? Agilent Technologies Inc trades at $128.2 (market cap $37.04B), while Manchester United PLC trades at $21.85 (market cap $3.85B). The key difference: Agilent Technologies Inc is far larger — about 9.6× Manchester United PLC's market cap, and Manchester United PLC pays the higher dividend (1.26%). Which is the better fit depends on your goals.
| A | MANU | |
|---|---|---|
Market Cap | $37.04B | $3.85B |
Sector | Health | Media |
52-Week High | $157.20 | $23.53 |
52-Week Low | $110.24 | $15.10 |
Enterprise Value | $38.59B | $4.77B |
Dividend Yield | 0.78% | 1.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
Manchester United (MANU) trades at $22.35, down 3.29% on the day, with a bullish technical outlook from moving averages but mixed oscillators. The company reported Q1 2026 EPS of $0.04, beating expectations, while revenue trends show modest growth to $667M in 2025. Recent news highlights stadium expansion plans and Champions League qualification as positive catalysts, though profitability remains challenged with a net income margin of -4.96% in 2025.
The outlook is cautiously optimistic with analyst consensus leaning hold (60%) amid valuation concerns (P/S 4.25, P/B 16.21). Key opportunities include revenue upside from new stadium and European competition, while risks involve persistent losses, high debt, and sports performance volatility. The stock's proximity to its 52-week high of $24.22 suggests limited near-term upside without fundamental improvement.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Manchester United PLC
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →
